Get the Stockscreener App
19.56
1.36%
-0.27
After Hours:
19.65
0.09
+0.46%
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $19.56, with a volume of 25.14M.
It is down -1.36% in the last 24 hours and up +10.45% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
See More
Previous Close:
$19.83
Open:
$19.66
24h Volume:
25.14M
Relative Volume:
1.27
Market Cap:
$37.56B
Revenue:
$15.29B
Net Income/Loss:
$1.62B
P/E Ratio:
23.19
EPS:
0.8433
Net Cash Flow:
$1.82B
1W Performance:
+2.57%
1M Performance:
+10.45%
6M Performance:
+16.78%
1Y Performance:
-7.08%
1-Day Range:
$19.27
$19.75
1-Week Range:
$18.89
$19.87
52-Week Range:
$14.02
$22.87
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
19.56 | 36.69B | 15.29B | 1.62B | 1.82B | 0.8433 |
PG
Procter Gamble Co
|
149.31 | 341.47B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
61.58 | 129.46B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
93.39 | 73.36B | 20.80B | 2.22B | 3.77B | 2.5772 |
KMB
Kimberly Clark Corp
|
113.01 | 36.44B | 16.56B | 1.75B | 1.84B | 6.36 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Jefferies | Buy → Hold |
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kenvue (KVUE) Faces A $48.7 Billion Kimberly Clark Deal And Big Portfolio Questions - Yahoo Finance UK
Should You Buy Kenvue Inc. (KVUE)’s Shares? - Yahoo Finance
Form 4 Kenvue Inc For: 1 July By Investing.com - Investing.com Canada
Kenvue (KVUE) director adds 1,413 DSUs, Starboard-linked holdings at 27.3M shares - Stock Titan
Kenvue (KVUE) director Richard Allison granted 1,413 deferred share units as board fees - Stock Titan
hould You Buy Kenvue Inc. (KVUE)’s Shares? - Yahoo! Finance Canada
The Neutrogena Oil-Free Acne WashKenvue Inc. targets US teens with a steady skincare anchor - AD HOC NEWS
MFS Intrinsic Equity Fund's Kenvue Inc(KVUE) Holding History - GuruFocus
Trading the Move, Not the Narrative: (KVUE) Edition - Stock Traders Daily
Kenvue surpasses 2025 plastic reduction target, falls short on recyclability - Packaging Dive
Listerine Smart Rinse from Kenvue Inc.kid-focused mouthwash adds fluoride and flavor - AD HOC NEWS
Listerine Cool Mint Mouth Wash from Kenvue Inc.classic formula, fresh burn and broad sizes - AD HOC NEWS
Kenvue updates guidance and restructuring plans, shares track broader healthcare sector - AD HOC NEWS
Kenvue with a clear analyst picture, shares extend a strong June run - AD HOC NEWS
Kenvue consensus shapes the week, shares track NYSE performance - Ad-hoc-news.de
Kenvue highlights consumer health portfolio, shares trade steadily on the NYSE - Ad-hoc-news.de
Listerine Antiseptic Mouthwash from Kenvuebold mint, family size and plaque control - Ad-hoc-news.de
Listerine Cool Mint Mouthwash from Kenvue Inc.classic 500 ml formula stays a daily habit - Ad-hoc-news.de
Kenvue focuses on consumer health portfolio, shares in S&P 500 peer comparison - Ad-hoc-news.de
Price to earnings forward of Kenvue Inc. – NYSE:KVUE - TradingView
Price to book forward of Kenvue, Inc. – FWB:J4D - TradingView
Kenvue, Inc. Actuals & Estimates (NYSE:KVUE) - TradingView
Kenvue (KVUE) Holds Steady Above Support as Consumer Health Sector Faces Mixed SentimentPut Dominated - dars.gov.et
J&J, Kenvue, Sued Over Autism by Texas, Look to Lack State Ties - Bloomberg Law News
Kenvue edges higher on NYSE, shares trade near recent range - Ad-hoc-news.de
Price to sales forward of Kenvue Inc. – NYSE:KVUE - TradingView
TYLENOL® Introduces PainTalk to Break the Silence on Pain--So Relief Can Start Sooner - PR Newswire
Oak Family Advisors LLC Increases Position in Kenvue Inc. $KVUE - MarketBeat
Enterprise value to revenue forward of Kenvue Inc. – NYSE:KVUE - TradingView
Kenvue Inc (KVUE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Kenvue Inc. stock rises Wednesday, outperforms market - MarketWatch
Kenvue shares rise as Kimberly-Clark deal spread holds near 2% - TechStock²
SG Americas Securities LLC Sells 613,737 Shares of Kenvue Inc. $KVUE - MarketBeat
The Neutrogena Ultra Sheer Dry-Touch SPF 55 from Kenvue Inc.high protection in a light everyday l - Ad-hoc-news.de
Kenvue Inc. stock rises Tuesday, outperforms market - MarketWatch
Kenvue highlights dividend profile, analysts map out KVUE shares on the NYSE - Ad-hoc-news.de
Kenvue Inc. stock falls Monday, underperforms market - MarketWatch
VanEck Morningstar Wide Moat Fund's Kenvue Inc(KVUE) Holding History - GuruFocus
3 Monster Dividend Stocks to Hold for the Next 10 Years - The Motley Fool
(KVUE) Volatility Zones as Tactical Triggers - Stock Traders Daily
Kenvue StockWeekly review and consumer health sector check - AD HOC NEWS
Piper Sandler Raises Kimberly-Clark (KMB) Price Target, Sees Long-Term Upside from Kenvue Deal - Yahoo Finance
Santher seeks role in Brazil review of Kimberly-Kenvue deal, cites dominance concerns - MLex
Kenvue stock: Is Wall Street bullish or bearish? - MSN
Kimberly-Clark's new structure sets stage for Kenvue integration - MSN
Capitolis Liquid Global Markets LLC Acquires 10,050,999 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc (KVUE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Armistice Capital LLC Makes New Investment in Kenvue Inc. $KVUE - MarketBeat
Is Kenvue stock underperforming the S&P 500? - MSN
Kenvue Inc (KVUE) Institutional Confidence - TradingKey
Kenvue Inc (KVUE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.49%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):